Form 4: Core Laboratories Director Katherine Murray Reports Stock Transactions
SEC Form 4 Filing
Director Katherine Murray reports acquisition and disposal of Core Laboratories Inc. common stock and restricted shares on April 1, 2024.
Summary
- Katherine Murray, a director of Core Laboratories Inc., reported transactions involving the company's common stock and restricted shares.
- On April 1, 2024, Murray acquired 9,317 restricted shares at $0, which will vest on April 1, 2025.
- On the same day, 6,419 restricted shares vested and were disposed of at $0.
- Following these transactions, Murray directly owns 9,317 restricted shares and 11,904 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock transactions: acquisition and disposal of restricted shares. |
| 04/01/2025 | Vesting date for the acquired restricted shares. |
| 04/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.